We talk with STAT News reporter Lizzy Lawrence about the agency’s recent turmoil and its hunt for a new leader.
Prescription Drugs
The U.S. Saved $1 Trillion on Health Care. Why Doesn’t It Feel Like It?
New research from leading health economist David Cutler explores what’s behind a historic slowdown in health spending, even as millions of Americans struggle to afford their care.
Should People Who Want GLP-1s Have to Work for Them?
As demand for new weight loss drugs soars, some employers are making workers track their diet and exercise in hopes of limiting use and keeping costs down.
GLP-1s Are Busting Employer Budgets. Some Are Getting Creative to Lower Costs.
From obesity management programs to rebates and apps, employers are experimenting with new approaches to make GLP-1 costs more sustainable.
How a Supreme Court Fight Over Fish Oil Could Raise Your Prescription Drug Costs
The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business.
Generic Drugs Head to the Supreme Court
The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business.
Rising Costs, Fewer Choices: What’s Up with Medicare Drug Plans?
Facing mounting financial pressures, insurance companies are changing the prescription drug coverage available to many consumers in Medicare Part D.
What Would Actually Lower Drug Prices in America? Experts Weigh In
Some of America’s top scholars on prescription drug pricing outline steps the Trump administration could take to make medicines more affordable.
Will Trump’s Prescription Drug Deals Really Lower Prices?
Facing unprecedented pressure from the Trump administration, some of the world’s top drugmakers promise to cut prices. But experts say the savings might not be what they seem.
Trump Forced Hospitals and Insurers to Reveal Their Prices. What Happened?
President Trump is revisiting one of the signature health policies of his first administration: making health care prices public. It hasn’t gone smoothly. Now Trump is calling for new rules and more public prices to deliver on his goal of a more competitive — less costly — health care market.
